Nest Health, the leading family-centered, home-based healthcare provider for high-risk families, announced the launch of Nest Rooted Recovery, a new Medication for Opioid Use Disorder program. The program brings evidence-based addiction treatment into the home while integrating ongoing medical, behavioral, and social care for the entire family.

Health Technology Insights: Arvinas and Pfizer’s Vepdegestrant Boosts Survival in Breast Cancer

Unlike traditional programs addressing substance use disorder or mental health in isolation, Nest Rooted Recovery is embedded within Nest’s fully integrated care model. Pregnant and non-pregnant adults receive not only life-saving addiction treatment but also continuous access to primary care, chronic condition management, mental health services, and social care — all delivered at home and online by the trusted Nest care team.

The need for innovative treatment models is urgent. The CDC reports that in 2022, nearly 108,000 people in the U.S. died from drug overdoses, with opioids, especially fentanyl, driving the crisis. Yet, fewer than 36% of individuals with opioid use disorder receive any treatment. Nest Health’s Rooted Recovery program removes common barriers to care, including transportation, stigma, and fragmented services, by meeting patients where they feel safest: at home.

“I’m so proud of this program — it provides much-needed access to treatment into the homes of families who deserve compassionate support, dignity, and a real chance at recovery,” said Kelsie Brandt, Chief Clinical Officer at Nest Health. “Our incredible clinical team provides care in the real context of people’s lives, always without judgment, with an unwavering commitment to helping our families thrive.”

Comprehensive, Coordinated In-Home Care for Opioid Use Disorder

Nest Rooted Recovery is built on evidence-based clinical protocols and best practices from organizations such as SAMHSA, ACOG, WHO, CDC, and NIDA. The program includes:

Health Technology Insights: Baker Tilly and MediSpend Launch stewardshipNOW for Compliance

  • In-Home Clinical Assessments evaluating opioid dependence severity (DSM-5 criteria), concurrent substance use, infectious diseases, toxicology (including fentanyl), and social determinants of health.
  • Medication Initiation and Monitoring with FDA-approved treatments and medications, primarily buprenorphine/naloxone, following safety-focused protocols to minimize withdrawal symptoms.
  • Pharmacy Coordination ensuring patients have timely access to medications and overdose prevention tools like naloxone.
  • Ongoing Monitoring with frequent provider check-ins during the first 72 hours and education on medication management and emergency response.
  • Seamless Transitions with warm handoffs to long-term recovery partners, including Odyssey House for in-person support and Eleanor Health for telehealth-based care.
  • Ongoing Medical, Mental and Social Care, with Nest continuing to provide recovery support, primary care, sick care, chronic disease management, specialist coordination, and check-ins with mental health specialists — ensuring continuity and checking potential hiccups in recovery early.

The Power of Home-Based, Family-Centered Care

Nest Health’s unique model addresses substance use disorder in the full context of patients’ lives. By delivering care in the home, the program not only eliminates logistical barriers but also enables providers to observe and address social and environmental factors that impact health and recovery. Furthermore, Nest’s whole-family approach ensures that care is comprehensive, coordinated, and designed to strengthen the family unit. The health of caregivers is deeply intertwined with the health of their children. When a parent is struggling, the effects ripple across the entire family. Addressing substance use and supporting caregiver health not only improves outcomes for the individual but also fosters better health, stability, and future opportunities for their children.

For Nest’s Medicaid plan partners, this program represents a scalable, high-impact solution that broadens access and improves outcomes across the continuum of care.

Health Technology Insights: Rad AI Appoints Demetri Giannikopoulos as Chief Growth Officer

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – PR Newswire